Synthetic Cannabinoid Agonist WIN 55212-2 Targets Proliferation, Angiogenesis, and Apoptosis <i>via</i> MAPK/AKT Signaling in Human Endometriotic Cell Lines and a Murine Model of Endometriosis.

Front Reprod Health · 2021 · PMC9580784 · PMID 36304004

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Although a positive trend was observed, no significant differences in MFI of c-JUN analytes were observed, except 1 μM concentration, in WIN55-treated cells compared with vehicle ( Figure 3J ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.